Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

7.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

14.1K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
14.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

964
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
964
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same author

Canal Construction Disrupts Camouflage in Two Sympatric Estuarine Crab Species.

Ecology and evolution·2026
Same author

Features of tumor microenvironment in HER2-positive urothelial carcinoma and its implications for immunotherapy resistance.

BMC cancer·2026
Same author

Effects of Pinglu Canal Construction on Camouflage in Two Sesarmid Crab Species.

Biology·2026
Same author

DeepSTFSynergy: A multi-scale structural information fusion method for personalized drug combination prediction.

Journal of biomedical informatics·2026
Same author

Corrigendum to "Risk factors, protective factors, peripheral biomarkers, and neurocognitive markers associated with mood disorders: An umbrella review of 103 meta-analyses and systematic reviews" [Brain, Behavior, Immunity Health 48 (2025) 1-27/101068].

Brain, behavior, & immunity - health·2026

Related Experiment Video

Updated: Apr 4, 2026

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

7.1K

Hemochromatosis osteoarthritis.

Yunze Yang1, Zhenyue Zu2, Yiran Huang3

  • 1Orthopedics and Traumatology, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.

Frontiers in Endocrinology
|April 3, 2026
PubMed
Summary

Hemochromatosis-associated arthropathy is a degenerative joint disease caused by iron overload, primarily damaging bone and cartilage. Treatment involves phlebotomy, iron chelation, and joint therapies to manage this progressive condition.

Keywords:
ferritinophagyferroptosishemochromatosisiron overloadosteoarthritistherapeutic strategy

More Related Videos

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
07:32

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

13.5K
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

7.1K
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
07:32

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

13.5K
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.5K

Area of Science:

  • Rheumatology
  • Orthopedics
  • Genetics

Background:

  • Hemochromatosis-associated arthropathy is a degenerative joint disease driven by pathological iron overload.
  • It primarily involves bone and cartilage destruction, differing from chronic synovitis-dominant arthropathies.
  • The condition presents with diverse systemic manifestations, including liver disease, diabetes, and hypothyroidism.

Purpose of the Study:

  • To provide a comprehensive overview of hemochromatosis-associated arthropathy.
  • To detail diagnostic approaches and current therapeutic strategies.
  • To discuss preventative measures for this iron overload-related joint disease.

Main Methods:

  • Review of current literature on hemochromatosis-associated arthropathy.
  • Analysis of diagnostic modalities including imaging (X-ray, CT, MRI, ultrasound), iron function tests, joint fluid analysis, and genetic testing.
  • Evaluation of treatment options such as phlebotomy, iron chelators, intra-articular injections, and surgery.

Main Results:

  • The disease is characterized by progressive bone and cartilage destruction due to iron overload.
  • Diagnosis integrates imaging, biochemical tests, and potentially genetic analysis.
  • Effective management includes phlebotomy, iron chelation, and localized joint treatments.

Conclusions:

  • Hemochromatosis-associated arthropathy is a distinct degenerative joint disease requiring multidisciplinary management.
  • Early diagnosis and intervention are crucial for mitigating joint damage and systemic complications.
  • Preventative strategies are essential for individuals at risk of iron overload disorders.